🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Lung cancer is the cancer with the highest morbidity and mortality among me...
Status
Recruiting
Location
Hubei Cancer Hospital
Start Date
2024-02-01
Trial ID
NCT06032052
Treatments Being Tested
This trial is being done to find out whether tisotumab vedotin works better...
Status
Completed
Location
Arizona Oncology Associates, PC - HAL
Start Date
2021-02-22
Trial ID
NCT04697628
Treatments Being Tested
This is an open-label, multicenter, randomized, phase 3 trial to evaluate t...
Status
Unknown
Location
Affiliated Cancer Hospital and Institute of Guangzhou Medical University
Start Date
2022-02-15
Trial ID
NCT05244642
Treatments Being Tested
The last ASCO recommendations in 2003 for the treatment of a CBNPC of stage...
Status
Completed
Location
CH - Pneumologie
Start Date
2006-03
Trial ID
NCT00298415
Treatments Being Tested
The aim of evaluating the efficacy and safety of cadonilimab combined with ...
Status
Recruiting
Location
Department of Medical Oncology, Central Hospital of Yichang City, the First Clinical Medical College of Three Gorges University
Start Date
2024-03-01
Trial ID
NCT06467500
Treatments Being Tested
The primary objective of this study is to assess and compare the efficacy a...
Status
Completed
Location
HonorHealth Research Institute
Start Date
2019-05-08
Trial ID
NCT03901339
Treatments Being Tested
This study is a Phase III, randomised, open label, multi-centre study asses...
Status
Completed
Location
Research Site
Start Date
2015-01-13
Trial ID
NCT02352948
Worldwide, breast cancer is the most incident and prevalent cancer among wo...
Status
Unknown
Location
Multiple Locations
Start Date
2018-02-08
Trial ID
NCT03423849
Treatments Being Tested
This is an open-label, multicenter, basket trial Phase II study to evaluate...
Status
Terminated
Location
University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center
Start Date
2018-02-19
Trial ID
NCT03386721
Pyrotinib is an oral tyrosine kinase inhibitor targeting both HER-1 and HER...
Status
Unknown
Location
Fudan University Shanghai Cancer Center
Start Date
2021-09-15
Trial ID
NCT05346861
Treatments Being Tested